Rachel Rabinovitch, MD

home / authors / rachel-rabinovitch-md

Articles

38 Comparing Risk Stratification and Radiotherapy Benefit for Patients With DCIS Using a 7-Gene Biosignature as Compared to a Clinicopathologic Nomogram

Julie A. Margenthaler, MD;Karuna Mittal;Frank A. Vicini, MD;Chirag Shah, MD;Rachel Rabinovitch, MD;Pat W. Whitworth;Brian Czerniecki;David J. Dabbs;G. Bruce Mann;Fredrik Wärnberg;Sheila Weinmann;Michael Leo;Steven C. Shivers;Troy Bremer

April 26th 2023

39 7-Gene Predictive Biosignature Improves Risk Stratification for Breast Ductal Carcinoma In Situ Patients Compared to Clinicopathologic Criteria, Identifying a Low-Risk Group Not Clinically Benefiting from Adjuvant Radiotherapy

Rachel Rabinovitch, MD;Frank A. Vicini, MD;Chirag Shah, MD;Julie A. Margenthaler, MD;Brian Czerniecki;Pat W. Whitworth;David J. Dabbs;G. Bruce Mann;Fredrik Wärnberg;Sheila Weinmann;Michael Leo;Jess Savala;Steven C. Shivers;Karuna Mittal;Troy Bremer

April 26th 2023

40 Characterization of Recurrence Risk After Lumpectomy and Radiotherapy in HER2-Positive Ductal Carcinoma in Situ of the Breast Using a 7-Gene Predictive Biosignature: Implications for the NSABP-B43 Trial Results

Frank A. Vicini, MD;Chirag Shah, MD;Rachel Rabinovitch, MD;Pat W. Whitworth;Julie A. Margenthaler, MD;Brian Czerniecki;David J. Dabbs;Sheila Weinmann;Michael Leo;G. Bruce Mann;Fredrik Wärnberg;Jess Savala;Steven C. Shivers;Karuna Mittal;Troy Bremer

April 26th 2023

37 The Routine Use of Bioimpedance Spectroscopy Measurements in the Clinic as a Surrogate for Bone Mineral Content in Oncology Patients: Practical Application of the SOZO Device

Steven C. Shivers;Pat W. Whitworth;Rachel Rabinovitch, MD;Frank Vicini, MD;Chirag Shah, MD;Fredrik Wärnberg;G. Bruce Mann;Karuna Mittal;Troy Bremer

May 6th 2022

38 Clinicopathological Risk Factors, Poorly Stratified Baseline Risk, and RT Benefit Compared to DCISionRT in Patients With Ductal Carcinoma in Situ

Pat W. Whitworth;Rachel Rabinovitch, MD;Frank A. Vicini, MD;Chirag Shah, MD;Fredrik Wärnberg;G. Bruce Mann;Steven C. Shivers;Karuna Mittal;Troy Bremer

May 6th 2022

Don’t Be Fooled by DCIS

Regina J. Brown, MD;Sharon Sams, MD, MPH;Dulcy E. Wolverton, MD;Tae Chong, MD;Virginia F. Borges, MD, MMSc;Rachel Rabinovitch, MD;Colleen D. Murphy, MD

July 15th 2017

A 46-year-old woman had a routine screening mammogram that showed new calcifications in the posterior left breast. A diagnostic mammogram showed several small punctate calcifications, and a 6-month interval follow-up was recommended.

Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies

Linda Overholser, MD, MPH;Elena Shagisultanova, MD, PhD;Rachel Rabinovitch, MD;Nicole Kounalakis, MD;Jennifer Diamond, MD;Christina A. Finlayson, MD;Christine M. Fisher, MD, MPH;Peter Kabos, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc;Jose Mayordomo, MD, PhD

December 15th 2016

We review available strategies for screening and risk reduction through chemoprevention or risk-reducing surgery, as well as challenges for management of breast cancer in patients with prior exposure to radiation for Hodgkin lymphoma.

A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma

Regina J. Brown, MD;Colleen D. Murphy, MD;Gwen H. Lisella, MD;Arlene L. Libby, MD;Uchenna O. Njiaju, MD;Rachel Rabinovitch, MD;Virginia F. Borges, MD, MMSc

July 16th 2016

A 40-year-old woman noted a large mass in her right breast. A diagnostic mammogram and ultrasound confirmed a 3.4-cm mass with associated microcalcifications.

Early-Stage BRCA2-Linked Breast Cancer Diagnosed in the First Trimester of Pregnancy Associated With a Hypercoagulable State

Jennifer R. Diamond, MD;Christina A. Finlayson, MD;Christiane Thienelt, MD;Peter Kabos, MD;Laura Hardesty, MD;Linda Barbour, MD, MSPH;Catherine E. Klein, MD;Rachel Rabinovitch, MD;Anthony D. Elias, MD;Virginia F. Borges, MD, MMSc

August 17th 2009

This feature examines the case of a patient with newly diagnosed breast cancer in the setting of a first-trimester pregnancy presenting to our multidisciplinary breast cancer clinic.

A Young Woman With a Small ER-Positive Breast Cancer, a Micrometastatic Axillary Lymph Node, and an Intermediate Oncotype DX Recurrence Score

Daniel W. Bowles, MD;Rachel Rabinovitch, MD;Virginia F. Borges, MD, MMSc;Alexander Urquhart, MD;Meenakshi Singh, MD;Christina A. Finlayson, MD;Anthony D. Elias, MD

September 1st 2007

patient is a 39-year-old premenopausal woman who presents with a new diagnosis of breast cancer to our multidisciplinary second opinion clinic.

A Woman With Primary Breast Cancer and a Solitary Sternal Metastasis

Alexander Menter, MD;Alexander Urquhart, MD;Virginia F. Borges, MD, MMSc;Rachel Rabinovitch, MD;Meenakshi Singh, MD;William Robinson, MD, PhD;Paul Seligman, MD;Christina A. Finlayson, MD;Anthony D. Elias, MD

August 1st 2006

The patient presented to her primary care physician 3 months prior with an inverted left nipple and a palpable lump that was highly suggestive of neoplasm on mammogram. An ultrasound-guided core biopsy revealed an infiltrating solid-type ductal carcinoma in situ. The estimated size of the mass was approximately 1 cm. She had no symptoms suggestive of metastatic disease.